Portfolio Update

RNS Number : 0238C

Intl. Biotechnology Trust PLC

05 November 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update

The Board of International Biotechnology Trust plc (the "Company") notes a further investment in the unquoted Swiss portfolio company Delenex Therapeutics ("Delenex").  Delenex was created to hold the non-ophthalmic assets of ESBATech when that company was sold to Alcon in September 2009, with the ownership structure mirroring that of ESBATech.

The Company has invested a further SFR88k (£53k) in Delenex as part of a SFR3.0m (£1.8m) bridging loan to a series A round of financing. This investment brings the total invested in Delenex to £186k with a value of £188k.

Enquiries:

Kate Bingham/David Pinniger

Telephone: [phone]       

SV Life Sciences Managers LLP   

Investment Manager                                        

Rachael Nelson

Telephone: [phone]

BNP Paribas Secretarial Services Limited

Company Secretary

5 NOVEMBER 2009

 

END

 

 

PFUBGBDBRDGGGCU